THE BEST SIDE OF HEMGENIX

Range of suitable individuals: CDEC discussed the uncertainty in the volume of individuals with reasonably significant to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some clients who will be classified as getting mild or moderate ailment may have a critical bleeding